Australian Clinical Labs Ltd has released a press release.
1H22 Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Australian Clinical Labs Ltd on 6ix
In the deck
Story so far
Earlier from Australian Clinical Labs
- Appendix 4D
- Letter from Crescent Capital Partners
- Upgrade to 1H FY22 Pro Forma Expectations
- Completion of Medlab Acquisition
- Medlab Pathology - Investor Presentation
Later from Australian Clinical Labs
- Establishment of Dividend Reinvestment Plan
- S&P DJI Announces March 2022 Quarterly Rebalance
- Response to Market Enquiries
- FY22 Investor Presentation
- Appendix 4E - Preliminary Financial Report
Follow Australian Clinical Labs into a list and get an email when it puts out news.
Follow Australian Clinical Labs